company background image
SCD logo

Zentiva BVB:SCD Stock Report

Last Price

RON 4.52

Market Cap

RON 3.2b

7D

0%

1Y

61.4%

Updated

03 Dec, 2024

Data

Company Financials

SCD Stock Overview

Engages in the production and marketing of preparations and medicines for human use in Romania and internationally. More details

SCD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for SCD from our risk checks.

Zentiva S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zentiva
Historical stock prices
Current Share PriceRON 4.52
52 Week HighRON 4.60
52 Week LowRON 2.72
Beta0.36
11 Month Change13.00%
3 Month Change4.63%
1 Year Change61.43%
33 Year Change69.92%
5 Year Change46.75%
Change since IPO9,000.06%

Recent News & Updates

Take Care Before Diving Into The Deep End On Zentiva S.A. (BVB:SCD)

Jul 30
Take Care Before Diving Into The Deep End On Zentiva S.A. (BVB:SCD)

Recent updates

Take Care Before Diving Into The Deep End On Zentiva S.A. (BVB:SCD)

Jul 30
Take Care Before Diving Into The Deep End On Zentiva S.A. (BVB:SCD)

Zentiva S.A. (BVB:SCD) Doing What It Can To Lift Shares

Mar 02
Zentiva S.A. (BVB:SCD) Doing What It Can To Lift Shares

Zentiva's (BVB:SCD) Solid Earnings May Rest On Weak Foundations

May 24
Zentiva's (BVB:SCD) Solid Earnings May Rest On Weak Foundations

Zentiva (BVB:SCD) Has Gifted Shareholders With A Fantastic 201% Total Return On Their Investment

Mar 01
Zentiva (BVB:SCD) Has Gifted Shareholders With A Fantastic 201% Total Return On Their Investment

Zentiva S.A.'s (BVB:SCD) Stock Is Going Strong: Have Financials A Role To Play?

Jan 25
Zentiva S.A.'s (BVB:SCD) Stock Is Going Strong: Have Financials A Role To Play?

Zentiva S.A. (BVB:SCD) Investors Are Less Pessimistic Than Expected

Dec 18
Zentiva S.A. (BVB:SCD) Investors Are Less Pessimistic Than Expected

Shareholder Returns

SCDRO PharmaceuticalsRO Market
7D0%1.4%-2.1%
1Y61.4%7.2%7.2%

Return vs Industry: SCD exceeded the RO Pharmaceuticals industry which returned 6.6% over the past year.

Return vs Market: SCD exceeded the RO Market which returned 6.1% over the past year.

Price Volatility

Is SCD's price volatile compared to industry and market?
SCD volatility
SCD Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement3.9%
10% most volatile stocks in RO Market10.7%
10% least volatile stocks in RO Market2.4%

Stable Share Price: SCD has not had significant price volatility in the past 3 months compared to the RO market.

Volatility Over Time: SCD's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19621,035Simona Cocoswww.zentiva.ro

Zentiva S.A. engages in the production and marketing of preparations and medicines for human use in Romania and internationally. The company develops pharmaceutical products in various therapeutic areas, such as cardiovascular diseases, anti-inflammatory and pain-relieving medications, urologists, blood diseases, gastrointestinal and metabolic disorders, central nervous system, infections, respiratory systems, and other. It also offers educational materials for healthcare professionals and patients.

Zentiva S.A. Fundamentals Summary

How do Zentiva's earnings and revenue compare to its market cap?
SCD fundamental statistics
Market capRON 3.15b
Earnings (TTM)RON 270.78m
Revenue (TTM)RON 1.09b

11.6x

P/E Ratio

2.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SCD income statement (TTM)
RevenueRON 1.09b
Cost of RevenueRON 470.10m
Gross ProfitRON 623.98m
Other ExpensesRON 353.20m
EarningsRON 270.78m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.39
Gross Margin57.03%
Net Profit Margin24.75%
Debt/Equity Ratio0%

How did SCD perform over the long term?

See historical performance and comparison